Tradestie Institutional Equity Comparison Engine

SYK vs BSX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SYK Overall Edge

SYK Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BSX counters with relative strength in Valuation. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus BSX at 14.2x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BSX
SYK 19.0x vs BSX 14.2x Fwd P/E
Growth & Margin Winner SYK
Op Margin 24.0% vs 19.6% ยท YoY +7.6% vs +1.4%
Momentum & Technical Winner SYK
1Y -16.8% vs -58.3% ยท 52W Pos 36% vs 6%
Options & Structure Winner SYK
SURGE (5th %ile IV) vs CONSOLIDATION (53rd %ile IV)
SYK NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap $118.9B
1M Return +5.47%
1Y Return -16.77%
Forward P/E 19.0x
Unified AI Score
46.5 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 58.0 Mom 60.0
BSX NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$43.74
-1.35% 1D
Market Cap $64.1B
1M Return -1.46%
1Y Return -58.33%
Forward P/E 14.2x
Unified AI Score
58.8 / 100 HOLD
Tech 49.0 Fund 58.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SYK -16.77% BSX -58.33% Spread: +41.56 pp (SYK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SYK Revenue BSX Revenue SYK Op. Margin BSX Op. Margin Margin Edge
FY2018 $13.6B $9.82B 18.7% 15.3% SYK
FY2019 $14.9B $10.7B 18.2% 14.1% SYK
FY2020 $14.3B $9.91B 15.5% -0.8% SYK
FY2021 $17.1B $11.9B 15.1% 10.1% SYK
FY2022 $18.4B $12.7B 15.4% 13.0% SYK
FY2023 $20.5B $14.2B 19.0% 16.5% SYK
FY2024 $22.6B $16.8B 16.3% 15.5% SYK
FY2025 $25.1B $20.1B 19.5% 18.0% SYK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SYK (5) vs BSX (5)
Institutional Metric SYK BSX Criterion Row Winner
Market Capitalization Scale $118.9B $64.1B Larger Scale SYK
Trailing P/E Ratio Valuation 33.3x 18.6x Lower Multiple BSX
Forward P/E Ratio Valuation 19.0x 14.2x Lower Multiple BSX
Revenue Growth (YoY) Growth +7.6% +1.4% Higher Growth SYK
Operating Margin (TTM) Profitability 24.0% 19.6% Higher Margin SYK
Net Profit Margin Profitability 13.8% 16.6% Higher Margin BSX
Return on Equity (ROE) Capital Efficiency 16.0% 14.1% Higher ROE SYK
52-Week Range Position Momentum 36% ($267โ€“$389) 6% ($40โ€“$106) Stronger Trend SYK
Beta / 30D Volatility Risk Regime 0.22ฮฒ ยท 50% Vol 0.32ฮฒ ยท 45% Vol Lower Realized Risk BSX
Unified Institutional Score Composite Signal 46.5 / 100 (HOLD) 58.8 / 100 (HOLD) Higher Composite BSX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SYK vs BSX Buy Guide
SYK SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SYK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BSX CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BSX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SYK nor BSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.